|
Oxaprozin
|
|
| Systematic (IUPAC) name | |
| 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid | |
| Identifiers | |
| CAS number | |
| ATC code | M01 |
| PubChem | |
| Drug |
|
| Chemical data | |
| Formula | C18H15NO3 |
| Mol. mass | 293.317 g/mol |
| Pharmacokinetic data | |
| Bioavailability |
95% |
| Protein binding | 99% |
| Metabolism | Liver—65% oxidation and 35% glucuronic acid conjugation. 5% are active phenolic metabolites. |
| Half life | 54.9 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status | |
| Routes | Oral |
Oxaprozin, also known as Oxaprozinum, (sold under the names: Daypro or Duraprox) is a non-narcotic, Non-steroidal anti-inflammatory drug
This article is based on an article from Wikipedia, the free encyclopedia and is available
under the terms of
GNU Free Documentation License.
In the Wikipedia there is a
list with all authors of this article
available.
Comments for Oxaprozin:
No Comments found for Oxaprozin